Search results for "TotalSeq"
Selected Filters:
A simple way to avoid error: How to calibrate your pipettes in less than 10 minutes
With the right equipment and these best practices, compliant and efficient calibration has never been easier
High-resolution 2-photon polymerization (2PP) 3D printing now in China
Collaboration between UpNano and Husun Technologies brings 2PP 3D-printing to one of the world’s largest technology markets
Cytokine storm syndromes and the lab’s role in early intervention
A closer look at the markers that help distinguish HLH, CRS, and other cytokine storm syndromes
Precise antibiotic guidance in record time with QuickMIC
Man versus microbes – How can we reduce antimicrobial resistance?
In this guest editorial discover what remains in our arsenal to combat antibiotic resistance, and how HORIBA Medical is advancing responsible prescribing to protect patient outcomes
Increasing cell adherence with a hypoxia workstation
Experts explore how molecular diagnostics are reshaping infectious disease testing and patient care
From sepsis to syndromic panels, this SelectScience forum discussed how molecular diagnostics is setting new standards for accuracy, efficiency, and impact
How CLSI standards help international manufacturers navigate FDA regulatory approval with confidence
In this guest editorial from the Clinical and Laboratory Standards Institute (CLSI), explore FDA clearance pathways and how CLSI standards can help expedite regulatory approval
The SIFT-MS mobile laboratory: Pollution source identification
Lonza to expand bioscience testing offering with the acquisition of Redberry
Acquisition to include Red One™ solid-phase cytometry platform for rapid sterility and bioburden testing, which expands Lonza’s portfolio of automated, scalable solutions for pharmaceutical quality control
BUCHI introduces a new freeze-drying system developed for R&D environments
The timesaving Lyovapor™ L-210 sets new efficiency standards while maintaining reliable and stable cooling performance
Membrane emulsification transforms long-acting injectable manufacturing
A breakthrough approach that overcomes scale-up and consistency challenges in microsphere production
Teva and Prestige Biopharma enter license agreement for Tuznue commercialization in Europe
Tuznue is a biosimilar of Herceptin (trastuzumab), developed to offer a more cost-effective therapeutic alternative for patients
























